Adicet Bio, Inc. Patent Applications Rejected
1 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-12-06: Application 15579974; Invention T CELL RECEPTOR LIKE ANTIBODIES HAVING FINE SPECIFICITY; Applicant Adicet Bio Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2017-12-06 | 15579974 | T CELL RECEPTOR LIKE ANTIBODIES HAVING FINE SPECIFICITY | Adicet Bio Inc. | Abandoned -- Failure to Respond to an Office Action | US20180179283A1 | Mira PELED KAMAR Galit DENKBERG Yoram REITER Ilan BEER Keren SINIK Yael TEBOUL (ELBAZ) Yael SHPERBER (SERY) Reut EREL SEGAL Ravit OREN Dror Shmuel ALISHEKEVITZ | Israel Israel Israel Israel Israel Israel Israel Israel Israel Israel | XIAO, YAN |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |